Siemens

Siemens Presents New Product Lines for Angiography

Siemens HealthcareSiemens Healthcare has developed a revolutionary new X-ray tube and detector technology for its Artis Q and Artis Q.zen angiography systems to improve minimally invasive therapy of diseases such as coronary artery disease, stroke and cancer. In both the Artis Q and Artis Q.zen series, the new X-ray tube can help to identify small vessels up to 70 percent better than conventional X-ray tube technology. The Artis Q.zen combines this innovative Xray source with a new detector technology that supports interventional imaging in ultra-low dose ranges. This protects patients, doctors and medical staff, especially during longer interventions. With these new developments, presented for the first time at the 98th Congress of the Radiological Society of North America (RSNA), Siemens Healthcare has once again demonstrated its innovative strength and market competitiveness as part of its Agenda 2013 global Sector initiative.

Two hardware components are crucial for angiographic image quality: the X-ray tube and the detector. The X-rays emitted by the tube pass through the patient and hit the detector, which converts them to image signals.

The second generation of Siemens' flat emitter technology is key to the advances made in the Xray tube for the Artis Q and Artis Q.zen product lines. Instead of the coiled filaments used in conventional X-ray tubes, flat emitter technology is used exclusively in the new tube to emit electrons. Flat emitters enable smaller quadratic focal spots that lead to improved visibility of small vessels by up to 70 percent. Both physicians and patients benefit from a high level of detail in imaging-supported interventional therapy. Neurologists can more precisely measure the blood circulation in specific areas of the brain, for example; while stenoses in the heart's smallest blood vessels can be spotted in coronary angiography.

Examinations using ultra-low dose radiation
The Artis Q.zen series combines the X-ray tube with a detector technology that allows detection at ultra-low radiation levels. Artis Q.zen imaging can use doses as low as half the usual levels normally applied in angiography. This improvement is the result of several innovations, including a fundamental change in detector technology. Until now, almost all detectors have been based on amorphous silicon. The new crystalline silicon structure of the Artis Q.zen detector is more homogenous, allowing for more effective amplification of the signal, greatly reducing the electronic noise even at ultra-low doses.

The Artis Q.zen was developed to support better imaging quality at ultra-low-dose ranges, reducing the radiation exposure of patients, physicians, and medical staff. This is especially important in dose-sensitive application fields such as pediatric cardiology and radiology, or electrophysiology, which is being used on more and more patients as rates of cardiac arrhythmia increase in an aging population.

Innovative applications for interventional imaging
In addition to the hardware innovations are several software applications that improve interventional imaging. In coronary artery disease treatment, the applications allow precise correlation of angiography images with ultrasound images taken by a probe inside the coronary arteries. Stents are imaged in real-time during therapy, with motion stabilization created by simultaneous correction for the heartbeat.

Other new 3D applications can image the smallest structures inside the head. Their high spatial resolution is crucial for imaging intracranial stents or other miniscule structures, such as the cochlea in the inner ear. Moving organs such as the lungs can be imaged in 3D in less than 3 seconds, reducing the number of motion artifacts and the amount of contrast agent required. Through visualization and measurement of blood volumes in the liver or other organs, Siemens' functional 3D imaging provides a basis for planning therapies such as chemo-embolization of hepatic tumors.

Launched in November 2011 by the Siemens Healthcare Sector, "Agenda 2013" is a two-year global initiative to further strengthen the Healthcare Sector's innovative power and competitiveness. Specific measures will be implemented in four fields of action: Innovation, Competitiveness, Regional Footprint, and People Development.

Related news articles:

About Siemens Healthcare
The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source - from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 51,000 employees worldwide and operates around the world. In fiscal year 2012 (to September 30), the Sector posted revenue of 13.6 billion euros and profit of 1.8 billion euros.

Most Popular Now

Med-e-Tel 2016 - International Tele…

6 - 8 April 2016, Luxembourg. The 14th edition of Med-e-Tel, the International Telemedicine and eHealth Forum, is taking place this week at the Luxexpo Exhibition and Co...

Read more

Accelerate Your Digital Health Star…

The Grants4Apps® Accelerator is a mentoring program for digital health startups taking place in Berlin. This year's batch with five startups runs from August until Decemb...

Read more

Medelinked Platform Now Features Sy…

Medelinked, the online health platform that empowers healthcare engagement and management, now features the Medelinked Symptom Checker integrated as part of the Medelinke...

Read more

UMANICK has been Selected to Join t…

UMANICK has been selected among over 800 European start-ups from different sectors belonging to FIWARE Accelerator to enter its VIP Programme. UMANICK entered the eHealth...

Read more

Nottingham Hospitals Improve Patien…

Software designed by Therapists and ICT leads at Nottingham University Hospitals NHS Trust (NUH) and developed by Nervecentre Software is being used by Therapy staff at C...

Read more

eHealth Week 2016 Speakers Announce…

8 - 10 June 2016, Amsterdam, The Netherlands. Today the Dutch Ministry of Health, Welfare and Sport, the European Commission and HIMSS Europe announced the first confirm...

Read more

High in Calories and Low in Nutrien…

A new study from the University of Gothenburg show that adolescents like to present foods that are high in calories but low in nutrients in social media. Previous studies...

Read more

Brainlab Quentry First Online Medic…

Brainlab, a global leader in medical technology, today announced that it has received the EuroPriSe European Data Privacy Seal for Quentry® by Brainlab. The seal certifie...

Read more

Mathematics to Fight Cancer

Mathematicians and physicians at the University of Bonn have developed a new model for immunotherapy of cancer. The method could help to develop new treatment strategies ...

Read more

Are Humans the New Supercomputer?

The saying of philosopher René Descartes of what makes humans unique is beginning to sound hollow. 'I think - therefore soon I am obsolete' seems more appropriate. When a...

Read more

Medical Services via Smartphone: A …

19 - 21 April 2016, Berlin, Germany. As the digital revolution progresses, medical services are now appearing on many people’s smartphones. The mHealth market featuring ...

Read more

Microsoft's Xbox Kinect Breathes Ne…

Xbox Kinects could be used in the future to assess the health of patients with conditions such as cystic fibrosis. Researchers at the Institute of Digital Healthcare, WMG...

Read more

Digest Newsletter

Subscribe to our weekly Newsletter and stay updated on the latest eHealth News. Subscribe now, it's free!
© eHealthNews.eu 2006 - 2016